Acadia Pharmaceuticals | ACAD - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $0 in Debt for its fiscal quarter ending in June of 2022.


Debt Change
ALKERMES ALKS:US USD 292.64M 635K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 1.48M
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Cytokinetics CYTK:US USD 610.62M 995K
Eisai 4523:JP JPY 126.1B 24.02B
Eli Lilly LLY:US USD 18.88B 2.64B
Incyte Corp INCY:US USD 32.85M 414K
Intercept Pharmaceuticals ICPT:US USD 333.04M 367K
J&J JNJ:US USD 52.91B 13.25B
Marinus Pharmaceuticals MRNS:US USD 71.5M 480K
Moderna Inc MRNA:US USD 984M 89M
Neurocrine Biosciences NBIX:US USD 169.5M 100K
PTC Therapeutics PTCT:US USD 1.35B 3.4M
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M